A new study finds that treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2) A new study finds that ...

Neurofibromatosis type 2 is most often diagnosed based on the presence of physical symptoms that are part of the specific diagnostic criteria for the disorder. Genetic testing for the NF2 mutation is ...

As a worldwide leader in neurofibromatosis, our program is dedicated to caring for patients and families affected by NF with expert diagnosis, treatment, and access to leading-edge research and ...